BRIEF published on 06/27/2025 at 22:22, 1 year 4 months ago KWS SAAT Divests North American Stakes in AgReliant GDM KWS SAAT Licensing Agreements AgReliant Genetics North American Corn Market
BRIEF published on 06/27/2025 at 22:22, 1 year 4 months ago KWS SAAT cède ses participations nord-américaines dans AgReliant Diabète Gestationnel KWS SAAT Accords De Licence Génétique AgReliant Marché Du Maïs Nord-américain
BRIEF published on 06/27/2025 at 22:05, 1 year 4 months ago NXT Energy Solutions: Conversion of Convertible Debentures by Mork Capital Common Shares Investment Strategy Convertible Debentures NXT Energy Solutions Mork Capital
BRIEF published on 06/27/2025 at 22:05, 1 year 4 months ago NXT Energy Solutions : Conversion d'obligations convertibles par Mork Capital Obligations Convertibles Stratégie D'investissement Actions Ordinaires Solutions Énergétiques NXT Mork Capital
BRIEF published on 06/27/2025 at 20:01, 1 year 4 months ago 1&1 AG Adjusts 2025 EBITDA Forecast EBITDA Forecast 1&1 AG Access Segment Vodafone Roaming Data Growth Costs
BRIEF published on 06/27/2025 at 20:01, 1 year 4 months ago 1&1 AG ajuste ses prévisions d'EBITDA pour 2025 1&1 AG Prévisions D'EBITDA Segment D'accès Itinérance Vodafone Coûts De Croissance Des Données
BRIEF published on 06/27/2025 at 19:35, 1 year 4 months ago Analyse des Résultats au 31 Mars 2025 de Crédit Agricole du Nord Liquidité Finance Solvabilité Crédit Agricole Risque De Crédit
BRIEF published on 06/27/2025 at 19:35, 1 year 4 months ago Analysis of the Results as of March 31, 2025 of Crédit Agricole du Nord Liquidity Finance Crédit Agricole Solvency Credit Risk
BRIEF published on 06/27/2025 at 19:19, 1 year 4 months ago ABIONYX Pharma Secures Approval for All General Meeting Resolutions Shareholder Approval General Meeting Biotech Innovation ABIONYX Pharma ApoA-I Technology
BRIEF published on 06/27/2025 at 19:19, 1 year 4 months ago ABIONYX Pharma obtient l'approbation de toutes les résolutions de l'assemblée générale Assemblée Générale Approbation Des Actionnaires Innovation Biotechnologique ABIONYX Pharma Technologie ApoA-I
Published on 11/20/2026 at 15:00, 2 days 4 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 2 days 4 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 2 days 5 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 2 days 5 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 2 days 5 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 1 day 19 hours ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 1 day 20 hours ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 1 day 21 hours ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 1 day 22 hours ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 2 days ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 2 days ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 2 days 1 hour ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 2 days 1 hour ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026